Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy

NCT03526263 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03526263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03526263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2018
Completion date
November 29, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery candidate, obesity, obesity, morbid, obesity; endocrine